why choose us

First received: December 08, 2023

Clinical Trial: Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Dry Eye

Study Type: INTERVENTIONAL


Official Title: Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers

Brief Summary: Miebo (Perfluorohexyloctane) is a novel, non-aqueous, single entity, preservative free, ophthalmic drop.This drop was recently approved by the Food and Drug Administration (FDA) for the treatment of Meibomian Gland Disease (MGD).All published data on Miebo has been done in non-contact lens wearers.As contact lens dropout rates seem to be an ongoing problem for practitioners, we are performing this study utilizing this novel new drug with contact lens patients to determine if the drops assist comfort in typical…

Read more